Hanmi Pharm 1Q26 OP -9.1% YoY, NP +14.4%
-
Sales 392.9B KRW (YoY +0.5%, QoQ -9.2%) -
Operating profit 53.7B KRW (YoY -9.1%, QoQ -35.6%) -
Net income 51.1B KRW (YoY +14.4%, QoQ -5.5%) -
R&D expenses 65.2B KRW (16.6% of sales) -
Preliminary, not yet audited
KOSPI Filing Information
- Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
- Company: Hanmi Pharm (128940)
- Submission: Hanmi Pharm. Co., Ltd.
- Receipt: 04-30-2026
- Under KRX KOSPI Market Division